References
- Van Slyck E J, Weiss L, Dully M. Chromosomal evidence for the secondary role of fibroblastic proliferation in acute myelofibrosis. Blood 1970; 36: 729–735
- Demory J L, Dupriez B, Fenaux P, Lai J L, Beuscart R, Jouet J P, et al. Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases. Blood 1988; 72: 855–859
- Reilly J T, Snowden J A, Spearing R L, Fitzgerald P M, Jones N, Watmore A, Potter A. Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases. Br J Haematol 1997; 98: 96–102
- Andrieux J, Demory J L, Morel P, Plantier I, Dupriez B, Caulier M T, et al. Frequency of structural abnormalities of the long arm of chromosome 12 in myelofibrosis with myeloid metaplasia. Cancer Genet Cytogenet 2002; 137: 68–71
- Andrieux J, Demory J L, Dupriez B, Quief S, Plantier I, Roumier C, et al. Dysregulation and overexpression of HMGA2 in Myelofibrosis with Myeloid Metaplasia. Genes, Chromosomes Cancer 2004; 39: 82–87
- Barosi G, Viarengo G, Pecci A, Rosti V, Piaggio G, Marchetti M, Frassoni F. Diagnostic and clinical relevance of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia. Blood 2001; 98: 3249–3255
- Barosi G, Ambrosetti A, Finelli C, Grossi A, Leoni P, Liberato N L, et al. The Italian consensus conference on diagnostic criteria for myelofibrosis with myeloid metaplasia. Br J Haematol 1999; 104: 730–737
- Rommel B, Rogalla P, Jox A, Kalle C V, Kazmierczak B, Wolf J, Bullerdiek J. HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells. Leuk Lymphoma 1997; 26: 603–607
- Mantovani F, Covaceuszach S, Rustighi A, Sgarra R, Heath C, Goodwin G H, Manfioletti G. NF-kappaB mediated transcriptional activation is enhanced by the architectural factor HMGI-C. Nucleic Acids Res 1998; 26: 1433–1439
- Diana F, Sgarra R, Manfioletti G, Rustighi A, Poletto D, Sciortino M T, et al. A link between apoptosis and degree of phosphorylation of high mobility group A1a protein in leukemic cells. J Biol Chem 2001; 276: 11354–11361
- Battista S, Fidanza V, Fedele M, Klein-Szanto A J, Outwater E, Brunner H, et al. The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res 1999; 59: 4793–4797
- Ashar H R, Fejzo M S, Tkachenko A, Zhou X, Fletcher J A, Weremowicz S, et al. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 1995; 82: 57–65
- Baldassarre G, Fedele M, Battista S, Vecchione A, Klein-Szanto A J, Santoro M, et al. Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc Natl Acad Sci USA 2001; 98: 7970–7975
- Pierantoni G M, Santulli B, Caliendo I, Pentimalli F, Chiappetta G, Zanesi N, et al. HMGA2 locus rearrangement in a case of acute lymphoblastic leukemia. Int J Oncol 2003; 23: 363–367
- Odero M D, Grand F H, Iqbal S, Ross F, Roman J P, Vizmanos J L, et al. Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies. Leukemia 2005; 19: 245–252